Tumor Genotype Dictates Avapritinib and Sunitinib Efficacy in Advanced GIST
A systematic review reveals that avapritinib and sunitinib efficacy in advanced gastrointestinal stromal tumors is fundamentally stratified by tumor genotype.
A systematic review reveals that avapritinib and sunitinib efficacy in advanced gastrointestinal stromal tumors is fundamentally stratified by tumor genotype.
A study in Biology Direct reports that Actinidia chinensis polysaccharide reverses imatinib resistance in gastrointestinal stromal tumors by downregulating NPM1 ...
A novel SDHA L511P germline variant was identified as likely pathogenic after being linked to gastrointestinal stromal tumors and paragangliomas ...
A case report documents increased uptake of the somatostatin-receptor PET probe 18F-AlF-NOTA-octreotide in a 45-year-old male patient diagnosed with a ...
An exploratory network meta-analysis found that extending adjuvant imatinib beyond three years reduced recurrence in selected high-risk gastrointestinal stromal tumor ...
A pilot study identifies a combination of endoscopic ultrasound features that accurately distinguishes nonumbilicated gastric heterotopic pancreas from gastrointestinal stromal ...
A case report documents nine months of stable disease in a patient with metastatic GIST treated with pembrolizumab after failing ...
A retrospective Tanzanian study of 60 CD117-positive gastrointestinal stromal tumors found that 12 cases, or 20.0 percent, were SDHB-negative, with ...
A newly developed liver metastasis mouse model shows that the gap junction protein Connexin 43, highly expressed in small intestinal ...
Analysis of 2,656 submissions across 20 UK NEQAS ICC & ISH assessment runs between May 2020 and May 2025 shows ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine